Identifying predictors for good lithium response - A retrospective analysis of 100 patients with bipolar disorder using a life-charting method

European Psychiatry

Volumn 24, Issue 3, 2009, Pages 171-177

  Backlund, Lena ^a   Ehnvall, Anna ^b   Hetta, Jerker ^a   Isacsson, Göran ^a   Ågren, Hans ^c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Institute for Clinical Neuroscience   (Sweden)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Bipolar disorder; Lithium; Treatment outcome

Indexed keywords

LAMOTRIGINE; LITHIUM; TOPIRAMATE; VALPROIC ACID;

ADULT; ARTICLE; BIPOLAR DISORDER; COMPUTER PROGRAM; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; HEALTH SURVEY; HUMAN; LATENT PERIOD; MAJOR CLINICAL STUDY; MALE; MANIA; ONSET AGE; PRIORITY JOURNAL; PROGNOSIS; REMISSION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ADULT; AGE OF ONSET; BIPOLAR DISORDER; FEMALE; HUMANS; LITHIUM COMPOUNDS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; PSYCHIATRIC STATUS RATING SCALES; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 63649118419     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2008.12.009     Document Type: Article

References (36)

1. Akiskal H.S. The prevalent clinical spectrum of bipolar disorders: beyond DSM-IV. J Clin Psychopharmacol 16 (1996) 4S-14S
2. Angst J., and Sellaro R. Historical perspectives and natural history of bipolar disorder. Biol Psychiatry 48 (2000) 445-457
3. Baethge C., Smolka M.N., Gruschka P., Berghofer A., Schlattmann P., Bauer M., et al. Does prophylaxis-delay in bipolar disorder influence outcome? Results from a long-term study of 147 patients. Acta Psychiatr Scand 107 (2003) 260-267
4. Baldessarini R.J., Tondo L., Baethge C.J., Lepri B., and Bratti I.M. Effects of treatment latency on response to maintenance treatment in manic-depressive disorders. Bipolar Disord 9 (2007) 386-393
5. Baldessarini R.J., Tondo L., and Hennen J. Treatment-latency and previous episodes: relationships to pretreatment morbidity and response to maintenance treatment in bipolar I and II disorders. Bipolar Disord 5 (2003) 169-179
6. Baldessarini R.J., Tondo L., and Viguera A.C. Discontinuing lithium maintenance treatment in bipolar disorders: risks and implications. Bipolar Disord 1 (1999) 17-24
7. Berk M., Hallam K., Lucas N., Hasty M., McNeil C.A., Conus P., et al. Early intervention in bipolar disorders: opportunities and pitfalls. Med J Aust 187 (2007) S11-S14
8. Bryant-Comstock L., Stender M., and Devercelli G. Health care utilization and costs among privately insured patients with bipolar I disorder. Bipolar Disord 4 (2002) 398-405
9. Denicoff K.D., Ali S.O., Sollinger A.B., Smith-Jackson E.E., and Leverich G.S. Post RM utility of the daily prospective National Institute of Mental Health Life-Chart Method (NIMH-LCM-p) ratings in clinical trials of bipolar disorder. Depress Anxiety 15 (2002) 1-9
10. Denicoff K.D., Leverich G.S., Nolen W.A., Rush A.J., McElroy S.L., Keck P.E., et al. Validation of the prospective NIMH-Life-Chart Method (NIMH-LCM-p) for longitudinal assessment of bipolar illness. Psychol Med 30 (2000) 1391-1397
11. Duffy A., Grof P., Robertson C., and Alda M. The implications of genetics studies of major mood disorders for clinical practice. J Clin Psychiatry 61 (2000) 630-637
12. Dunayevich E., Sax K.W., Keck Jr. P.E., McElroy S.L., Sorter M.T., McConville B.J., et al. Twelve-month outcome in bipolar patients with and without personality disorders. J Clin Psychiatry 61 (2000) 134-139
13. Dunayevich E., Strakowski S.M., Sax K.W., Sorter M.T., Keck Jr. P.E., McElroy S.L., et al. Personality disorders in first- and multiple-episode mania. Psychiatry Res 64 (1996) 69-75
14. Ehnvall A., and Ågren H. Patterns of sensitisation in the course of affective illness. A life-charting study of treatment-refractory depressed patients. J Affect Disord 70 (2002) 67-75
15. Ehnvall A., Sjögren M., Zachrisson O.C., and Ågren H. Lifetime burden of mood swings and activation of brain norepinephrine turnover in patients with treatment-refractory depressive illness. J Affect Disord 74 (2003) 185-189
16. Franchini L., Zanardi R., Smeraldi E., and Gasperini M. Early onset of lithium prophylaxis as a predictor of good long-term outcome. Eur Arch Psychiatry Clin Neurosci 249 (1999) 227-230
17. Goodwin F.K., and Jamison K.R. Manic-depressive illness: bipolar disorders and recurrent depression (2007), Oxford University Press, New York p. 120-5
18. Judd L.L., Akiskal H.S., Schettler P.J., Coryell W., Endicott J., Maser J.D., et al. A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Arch Gen Psychiatry 60 (2003) 261-269
19. Judd L.L., Akiskal H.S., Schettler P.J., Endicott J., Maser J., Solomon D.A., et al. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry 59 (2002) 530-537
20. Kessler R.C., McGonagle K.A., Zhao S., Nelson C.B., Hughes M., Eshleman S., et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 51 (1994) 8-19
21. Koukopoulos A., Sani G., Koukopoulos A.E., and Giraldi P. Cyclicity and manic-depressive illness (2000), Kluwer Academics, Dordrecht Chapter in a book
22. Leverich G.S., Nolen W.A., Rush A.J., McElroy S.L., Keck P.E., Denicoff K.D., et al. The Stanley foundation bipolar treatment outcome network. I. Longitudinal methodology. J Affect Disord 67 (2001) 33-44
23. Maj M. The impact of lithium prophylaxis on the course of bipolar disorder: a review of the research evidence. Bipolar Disord 2 (2000) 93-101
24. Marneros A., Deister A., and Rohde A. Affective, schizoaffective and schizophrenic psychoses. A comparative long-term study. Monogr Gesamtgeb Psychiatr Psychiatry Ser 65 (1991) 1-454
25. Miklowitz D.J., and Johnson S.L. The psychopathology and treatment of bipolar disorder. Annu Rev Clin Psychol 2 (2006) 199-235
26. Ösby U., Brandt L., Correia N., Ekbom A., and Sparén P. Excess mortality in bipolar and unipolar disorder in Sweden. Arch Gen Psychiatry 58 (2001) 844-850
27. Regier D.A., Boyd J.H., Burke Jr. J.D., Rae D.S., Myers J.K., Kramer M., et al. One-month prevalence of mental disorders in the United States. Based on five epidemiologic catchment area sites. Arch Gen Psychiatry 45 (1988) 977-986
28. Rohayem J., Bayle J.F., and Richa S. Predictors of prophylactic response to lithium. Encephale 34 (2008) 394-399
29. Sharma P., Basu D., and Thapar S. Latency and outcome of prophylaxis in bipolar disorder: role of severity as a confounding variable?. Acta Psychiatr Scand 109 (2004) 157 [author reply 158]
30. Sheehan D.V., Lecrubier Y., and Harnett-Sheehan K. Reliability and validity of the M.I.N.I International Neuropsychiatric Interview (M.I.N.I.): according to the SCID-P. Eur Psychiatry 12 (1997) 232-241
31. Skeppar P., and Adolfsson R. Bipolar II and the bipolar spectrum. Nord J Psychiatry 60 (2006) 7-26
32. Tondo L., Baldessarini R.J., Hennen J., and Floris G. Lithium maintenance treatment of depression and mania in bipolar I and bipolar II disorders. Am J Psychiatry 155 (1998) 638-645
33. Tondo L., Baldessarini R.J., Hennen J., Minnai G.P., Salis P., Scamonatti L., et al. Suicide attempts in major affective disorder patients with comorbid substance use disorders. J Clin Psychiatry 60 Suppl. 2 (1999) 63-69 [discussion 75-6, 113-6]
34. Tondo L., Isacsson G., and Baldessarini R. Suicidal behaviour in bipolar disorder: risk and prevention. CNS Drugs 17 (2003) 491-511
35. Vieta E., Pacchiarotti I., Scott J., Sanchez-Moreno J., Di Marzo S., and Colom F. Evidence-based research on the efficacy of psychological interventions in bipolar disorders: a critical review. Curr Psychiatry Rep 7 (2005) 449-455
36. Winokur G., Coryell W., Keller M., Endicott J., and Akiskal H. A prospective follow-up of patients with bipolar and primary unipolar affective disorder. Arch Gen Psychiatry 50 (1993) 457-465